-
Article
Open AccessRepositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
Non-alcoholic steatohepatitis (NASH) is a rising health challenge, with no approved drugs. We used a computational drug repositioning strategy to uncover a novel therapy for NASH, identifying a GABA-B receptor...
-
Chapter
Novel Methods for Addressing Immunogenicity of Therapeutic Enzymes
While the biotechnology revolution has contributed to the development of life-saving replacement proteins for blood factor and enzyme such as hemophilia and Pompe disease, these therapies can induce immune res...
-
Article
Open AccessIn Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity
Tregitopes are regulatory T cell epitopes derived from immunoglobulin G (IgG) that stimulate CD25+ FoxP3+ T cells to expand. In conjunction with these Tregs, Tregitopes can prevent, treat, and even cure autoimmun...
-
Article
Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer
Taurolidine (TRD) was designed in the 1970s as a broad-spectrum antibiotic and is used clinically at high doses without systemic toxicity. We have found that this agent possesses cytotoxic activity in human tu...
-
Article
Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
Induction of high systemic levels of type 1 interferons (IFNs) IFN-α and IFN-β is a hallmark of many viral infections. In addition to their potent antiviral effects, these cytokines mediate a number of immunor...
-
Chapter
Early Cytokine Responses to Viral Infections and Their Roles in Sha** Endogenous Cellular Immunity
Immune responses to different infectious agents have overlap** constituents. However, certain of these are induced to higher levels and/or play more important roles in defense under conditions of infections ...